Breaking down the cell wall: Still an attractive antibacterial strategy

Area of Science:

• Microbiology and Infectious Diseases
• Drug Discovery and Development
• Biochemistry

Background:

• Antibiotic resistance poses a significant global health challenge, necessitating the development of novel antimicrobial agents.
• Bacterial cell walls are essential for survival and are a validated target for many existing antibiotics.
• The emergence of resistance mechanisms underscores the urgent need for new strategies in antibiotic research.

Purpose of the Study:

• To provide a comprehensive review of bacterial cell wall targets for antimicrobial screening.
• To discuss established and emerging targets within peptidoglycan, lipopolysaccharide, teichoic acid, and lipoprotein synthesis pathways.
• To highlight innovative methodologies for accelerating the discovery of new antibiotics.

Main Methods:

• Review of existing literature on bacterial cell wall biosynthesis and antibiotic targets.
• Analysis of established targets such as MurA-F, Alr, Ddl, MurG, Lipid A, and BamA.
• Discussion of recent advancements in targeting MraY, MsbA, TagO, LtaS, LspA, Lgt, Lnt, Tol-Pal, MntC, and OspA.

Main Results:

• Identification of numerous essential bacterial cell wall biosynthesis targets, including those in peptidoglycan, lipopolysaccharide, and teichoic acid pathways.
• Elucidation of the historical progression and latest developments in targeting these essential bacterial components.
• Demonstration of the potential of new screening methodologies to identify novel antimicrobial compounds.

Conclusions:

• The bacterial cell wall remains a critical and diverse target for novel antibiotic development.
• Continued exploration of established and emerging targets, coupled with advanced screening techniques, is crucial for combating antibiotic resistance.
• Innovative approaches like structure-based drug design and compound library construction offer promising avenues for future antimicrobial discovery.